Literature DB >> 26305968

Synapse-specific IL-1 receptor subunit reconfiguration augments vulnerability to IL-1β in the aged hippocampus.

G Aleph Prieto1, Shikha Snigdha2, David Baglietto-Vargas2, Erica D Smith2, Nicole C Berchtold2, Liqi Tong2, Dariush Ajami3, Frank M LaFerla2, Julius Rebek4, Carl W Cotman1.   

Abstract

In the aged brain, synaptic plasticity and memory show increased vulnerability to impairment by the inflammatory cytokine interleukin 1β (IL-1β). In this study, we evaluated the possibility that synapses may directly undergo maladaptive changes with age that augment sensitivity to IL-1β impairment. In hippocampal neuronal cultures, IL-1β increased the expression of the IL-1 receptor type 1 and the accessory coreceptor AcP (proinflammatory), but not of the AcPb (prosurvival) subunit, a reconfiguration that potentiates the responsiveness of neurons to IL-1β. To evaluate whether synapses develop a similar heightened sensitivity to IL-1β with age, we used an assay to track long-term potentiation (LTP) in synaptosomes. We found that IL-1β impairs LTP directly at the synapse and that sensitivity to IL-1β is augmented in aged hippocampal synapses. The increased synaptic sensitivity to IL-1β was due to IL-1 receptor subunit reconfiguration, characterized by a shift in the AcP/AcPb ratio, paralleling our culture data. We suggest that the age-related increase in brain IL-1β levels drives a shift in IL-1 receptor configuration, thus heightening the sensitivity to IL-1β. Accordingly, selective blocking of AcP-dependent signaling with Toll-IL-1 receptor domain peptidomimetics prevented IL-1β-mediated LTP suppression and blocked the memory impairment induced in aged mice by peripheral immune challenge (bacterial lipopolysaccharide). Overall, this study demonstrates that increased AcP signaling, specifically at the synapse, underlies the augmented vulnerability to cognitive impairment by IL-1β that occurs with age.

Entities:  

Keywords:  AcP; AcPb; LTP; neuroinflammation; receptor sensitivity

Mesh:

Substances:

Year:  2015        PMID: 26305968      PMCID: PMC4568670          DOI: 10.1073/pnas.1514486112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  75 in total

1.  The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1β expression.

Authors:  Andrew J Tarr; Kristina A McLinden; Dinko Kranjac; Rachel A Kohman; Wellington Amaral; Gary W Boehm
Journal:  Behav Brain Res       Date:  2010-11-03       Impact factor: 3.332

2.  Role of glycine receptors in glycine-induced LTD in hippocampal CA1 pyramidal neurons.

Authors:  Rong-Qing Chen; Shan-Hui Wang; Wen Yao; Jing-Jing Wang; Fang Ji; Jing-Zhi Yan; Si-Qiang Ren; Zheng Chen; Su-Yi Liu; Wei Lu
Journal:  Neuropsychopharmacology       Date:  2011-05-18       Impact factor: 7.853

Review 3.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

4.  Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation.

Authors:  C A Murray; M A Lynch
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

5.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

6.  Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism.

Authors:  Karlie A Intlekofer; Nicole C Berchtold; Melissa Malvaez; Anthony J Carlos; Susan C McQuown; Michael J Cunningham; Marcelo A Wood; Carl W Cotman
Journal:  Neuropsychopharmacology       Date:  2013-04-24       Impact factor: 7.853

7.  IL-1RA blocks E. coli-induced suppression of Arc and long-term memory in aged F344xBN F1 rats.

Authors:  Matthew G Frank; Ruth M Barrientos; Amy M Hein; Joseph C Biedenkapp; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2009-10-12       Impact factor: 7.217

8.  Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression.

Authors:  I Goshen; T Kreisel; O Ben-Menachem-Zidon; T Licht; J Weidenfeld; T Ben-Hur; R Yirmiya
Journal:  Mol Psychiatry       Date:  2007-08-14       Impact factor: 15.992

9.  Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.

Authors:  Jeffrey A Fein; Sophie Sokolow; Carol A Miller; Harry V Vinters; Fusheng Yang; Gregory M Cole; Karen Hoppens Gylys
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

10.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  49 in total

1.  Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes.

Authors:  Opal V Potter; Megan E Giedraitis; Charles D Johnson; Mackenzie N Cox; Rachel A Kohman
Journal:  Brain Behav Immun       Date:  2018-10-27       Impact factor: 7.217

Review 2.  Neuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets.

Authors:  Francis J Herman; Sherry Simkovic; Giulio M Pasinetti
Journal:  Br J Pharmacol       Date:  2019-03-21       Impact factor: 8.739

Review 3.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

4.  Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses.

Authors:  G Aleph Prieto; Brian H Trieu; Cindy T Dang; Tina Bilousova; Karen H Gylys; Nicole C Berchtold; Gary Lynch; Carl W Cotman
Journal:  J Neurosci       Date:  2016-12-16       Impact factor: 6.167

Review 5.  Infectious immunity in the central nervous system and brain function.

Authors:  Robyn S Klein; Charise Garber; Nicole Howard
Journal:  Nat Immunol       Date:  2017-01-16       Impact factor: 25.606

Review 6.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

7.  Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells.

Authors:  De-Huang Guo; Masaki Yamamoto; Caterina M Hernandez; Hesam Khodadadi; Babak Baban; Alexis M Stranahan
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 8.  Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration.

Authors:  John V Pluvinage; Tony Wyss-Coray
Journal:  Nat Rev Neurosci       Date:  2020-01-08       Impact factor: 34.870

9.  Innate Immune Signaling and Alcohol Use Disorders.

Authors:  Leon G Coleman; Fulton T Crews
Journal:  Handb Exp Pharmacol       Date:  2018

10.  Cytokines and cytokine networks target neurons to modulate long-term potentiation.

Authors:  G Aleph Prieto; Carl W Cotman
Journal:  Cytokine Growth Factor Rev       Date:  2017-03-29       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.